GSK | GlaxoSmithKline plc ADR

CUSIP: 37733W105

0 Funds Holding

0 Total Shares

$0 Total Value

$122.1B

Market Cap

16.1

P/E Ratio

11.9

Forward P/E

$3.78

EPS (TTM)

2.93%

Dividend Yield

$3.4B

Cash

$17.0B

Total Debt

2.01B

Shares Out

$32.38

$61.02

52-Week Range

Fund / Manager Click to search	Shares	Value	% of Portfolio	Cost Basis	Est. Return
No funds currently hold this stock.

Quarter:

Fund / Manager Click to search	Action	Change	Shares After	Value	Price
2025-Q2
Kahn Brothers Group	SELL	EXIT	—	—	$38.28
2025-Q1
Kahn Brothers Group	SELL	-7.1%	822.2K	$32M	$36.55
2024-Q4
Kahn Brothers Group	SELL	-16.4%	884.7K	$30M	$35.52
2024-Q3
Kahn Brothers Group	SELL	-14.7%	1.1M	$43M	$40.71
2024-Q2
Kahn Brothers Group	SELL	-1.0%	1.2M	$48M	$41.24
2024-Q1
Kahn Brothers Group	SELL	-0.5%	1.3M	$54M	$41.90
2023-Q4
Kahn Brothers Group	SELL	-1.8%	1.3M	$47M	$35.99
2023-Q3
Kahn Brothers Group	BUY	+1.5%	1.3M	$46M	$35.18
2023-Q2
Kahn Brothers Group	SELL	-1.1%	1.3M	$45M	$36.03
2023-Q1
Kahn Brothers Group	BUY	+4.1%	1.3M	$45M	$35.10
2022-Q4
Kahn Brothers Group	SELL	-6.0%	1.2M	$43M	$33.17
Tweedy Browne Co.	SELL	EXIT	—	—	$33.17
2022-Q3
Dodge & Cox	SELL	EXIT	—	—	$34.95
Kahn Brothers Group	SELL	-8.8%	1.3M	$38M	$34.95
Ariel Investments	SELL	EXIT	—	—	$34.95
Hillman Capital Management	SELL	EXIT	—	—	$34.95
Tweedy Browne Co.	SELL	-23.5%	145.7K	$4M	$34.95
2022-Q2
Dodge & Cox	SELL	-13.4%	74.2M	$3.2B	$44.20
Kahn Brothers Group	BUY	+0.3%	1.4M	$62M	$44.20
Ariel Investments	BUY	+7.0%	263.1K	$11M	$44.20
Causeway Capital Management	SELL	EXIT	—	—	$44.20
Hillman Capital Management	BUY	+0.5%	236.8K	$10M	$44.20
Tweedy Browne Co.	SELL	-3.2%	190.4K	$8M	$44.20
2022-Q1
Dodge & Cox	SELL	-3.1%	85.8M	$3.7B	$43.39
Kahn Brothers Group	SELL	-0.8%	1.4M	$62M	$43.39
Causeway Capital Management	BUY	+44.7%	258.4K	$11M	$43.39
Ariel Investments	SELL	-2.8%	245.8K	$11M	$43.39
Hillman Capital Management	BUY	+1.1%	235.7K	$10M	$43.39
Tweedy Browne Co.	SELL	-1.4%	196.8K	$9M	$43.39
2021-Q4
Dodge & Cox	BUY	+0.6%	88.5M	$3.9B	$42.12
Kahn Brothers Group	BUY	+6.3%	1.4M	$63M	$42.12
Ariel Investments	SELL	-3.1%	252.8K	$11M	$42.12
Hillman Capital Management	SELL	-3.6%	233.1K	$10M	$42.12
Tweedy Browne Co.	BUY	+7.5%	199.7K	$9M	$42.12
Causeway Capital Management	BUY	NEW	178.5K	$8M	$42.12
2021-Q3
Dodge & Cox	SELL	-0.2%	88.0M	$3.4B	$40.24
Kahn Brothers Group	BUY	+4.3%	1.4M	$52M	$40.24
Hillman Capital Management	BUY	+3.5%	241.8K	$9M	$40.24
Tweedy Browne Co.	SELL	-1.7%	185.7K	$7M	$40.24
2021-Q2
Dodge & Cox	BUY	+0.3%	88.2M	$3.5B	$38.51
Kahn Brothers Group	BUY	+2.5%	1.3M	$52M	$38.51
Ariel Investments	SELL	-39.1%	260.9K	$10M	$38.51
Hillman Capital Management	BUY	+0.7%	233.6K	$9M	$38.51
Tweedy Browne Co.	SELL	-2.0%	188.9K	$8M	$38.51
2021-Q1
Dodge & Cox	BUY	+39.7%	87.9M	$3.1B	$36.03
Kahn Brothers Group	SELL	-1.3%	1.3M	$45M	$36.03
Ariel Investments	SELL	-25.9%	428.7K	$15M	$36.03
Hillman Capital Management	BUY	NEW	232.1K	$8M	$36.03
Tweedy Browne Co.	BUY	+26.1%	192.7K	$7M	$36.03
2020-Q4
Dodge & Cox	BUY	+39.9%	62.9M	$2.3B	$37.01
Kahn Brothers Group	SELL	-8.9%	1.3M	$47M	$37.01
Ariel Investments	SELL	-33.1%	578.9K	$21M	$37.01
Tweedy Browne Co.	SELL	-4.3%	152.8K	$6M	$37.01
Hillman Capital Management	BUY	NEW	5.6K	$207000	$37.01
2020-Q3
Dodge & Cox	BUY	+8.4%	45.0M	$1.7B	$40.30
Kahn Brothers Group	SELL	-7.3%	1.4M	$53M	$40.30
Ariel Investments	SELL	-15.4%	865.4K	$33M	$40.30
Tweedy Browne Co.	BUY	+2.6%	159.6K	$6M	$40.30
2020-Q2
Dodge & Cox	SELL	-5.7%	41.5M	$1.7B	$41.31
Kahn Brothers Group	SELL	-1.7%	1.5M	$62M	$41.31
Ariel Investments	SELL	-12.4%	1.0M	$42M	$41.31
Tweedy Browne Co.	SELL	-5.5%	155.5K	$6M	$41.31
2020-Q1
Dodge & Cox	SELL	-5.1%	44.0M	$1.7B	$43.74
Kahn Brothers Group	SELL	-2.8%	1.5M	$58M	$43.74
Ariel Investments	BUY	+0.0%	1.2M	$44M	$43.74
Tweedy Browne Co.	SELL	-3.7%	164.6K	$6M	$43.74
2019-Q4
Dodge & Cox	SELL	-4.0%	46.4M	$2.2B	$44.48
Kahn Brothers Group	SELL	-2.0%	1.6M	$75M	$44.48
Ariel Investments	SELL	-18.5%	1.2M	$55M	$44.48
Tweedy Browne Co.	SELL	-1.6%	171.0K	$8M	$44.48
2019-Q3
Dodge & Cox	BUY	+0.2%	48.3M	$2.1B	$41.11
Kahn Brothers Group	BUY	+1.0%	1.6M	$69M	$41.11
Ariel Investments	SELL	-2.9%	1.4M	$61M	$41.11
Tweedy Browne Co.	SELL	-3.6%	173.7K	$7M	$41.11
2019-Q2
Dodge & Cox	BUY	+0.3%	48.2M	$1.9B	$40.13
Ariel Investments	SELL	-11.2%	1.5M	$59M	$40.13
Kahn Brothers Group	BUY	+25.7%	1.6M	$64M	$40.13
Tweedy Browne Co.	SELL	-4.4%	180.1K	$7M	$40.13
Causeway Capital Management	SELL	EXIT	—	—	$40.13
2019-Q1
Dodge & Cox	BUY	+0.2%	48.1M	$2.0B	$40.28
Kahn Brothers Group	BUY	+1.2%	1.3M	$53M	$40.28
Causeway Capital Management	SELL	-99.5%	1.4K	$59000	$40.28
Tweedy Browne Co.	SELL	-0.4%	188.5K	$8M	$40.28
2018-Q4
Dodge & Cox	SELL	-0.0%	48.0M	$1.8B	$39.61
Ariel Investments	SELL	-2.6%	1.7M	$63M	$39.61
Kahn Brothers Group	BUY	+1.6%	1.3M	$48M	$39.61
Causeway Capital Management	SELL	-27.0%	284.6K	$11M	$39.61
Tweedy Browne Co.	SELL	-2.1%	189.3K	$7M	$39.61
2018-Q3
Dodge & Cox	SELL	-0.3%	48.0M	$1.9B	$40.76
Kahn Brothers Group	BUY	+0.4%	1.2M	$50M	$40.76
Causeway Capital Management	SELL	-9.0%	390.0K	$16M	$40.76
Tweedy Browne Co.	SELL	-0.3%	193.3K	$8M	$40.76
2018-Q2
Dodge & Cox	SELL	-0.8%	48.2M	$1.9B	$40.21
Ariel Investments	SELL	-3.8%	1.7M	$69M	$40.21
Kahn Brothers Group	BUY	+0.5%	1.2M	$50M	$40.21
Causeway Capital Management	SELL	-53.5%	428.5K	$17M	$40.21
Tweedy Browne Co.	SELL	-0.1%	194.0K	$8M	$40.21
2018-Q1
Dodge & Cox	BUY	+10.1%	48.6M	$1.9B	$37.13
Ariel Investments	SELL	-0.5%	1.8M	$69M	$37.13
Kahn Brothers Group	BUY	+8.0%	1.2M	$48M	$37.13
Causeway Capital Management	BUY	+46.1%	920.8K	$36M	$37.13
Tweedy Browne Co.	SELL	-1.6%	194.1K	$8M	$37.13

6 Months Insider Sentiment

100%

Buy $27.9M Sell $0

1 Buys

0 Sells

+27.9M Net

0 Grants

Largest

$27.9M plc

Date	Insider Click to search	Role Click to search	Type	Shares	Price	Value
Dec 11, 2025	GSK plc	10% Owner	BUY	1.47M	$19.00	$27.9M

GSK | GlaxoSmithKline plc ADR

Institutional Ownership of GlaxoSmithKline plc ADR

Trading Activity for GlaxoSmithKline plc ADR

Insider Trading for GlaxoSmithKline plc ADR